INS CD-PERIPHERAL ARTERY TEST
SB1418 amends multiple Illinois insurance-related statutes to require coverage for a peripheral artery disease screening test for at-risk individuals. The bill adds a new Section 356z.80 to the Illinois Insurance Code requiring group and individual accident and health insurance plans, managed care plans, and certain other regulated health plans issued, delivered, amended, or renewed on or after January 1, 2027 to cover medically necessary peripheral artery disease screening for individuals defined as at-risk under guidelines from the American College of Cardiology and the American Heart Association. It also updates related provisions in the State Employees Group Insurance Act, Counties Code, Municipal Code, School Code, Limited Health Service Organization Act, Voluntary Health Services Plans Act, and Public Aid Code so that the new screening benefit is incorporated across public employee, local government, school, HMO, and Medicaid-related coverage frameworks.
In addition to the new screening mandate, the bill makes conforming changes to existing health-benefit cross-references throughout the Illinois Insurance Code and related statutes. It preserves existing enforcement roles, generally assigning the Department of Insurance responsibility for enforcing the new insurance coverage requirement and maintaining the Department of Central Management Services’ role for other state employee health-benefit provisions. The bill also retains standard language limiting unauthorized rulemaking and clarifying that home rule units must comply with the mandated coverage requirements.
The overall sentiment around SB1418 appears strongly favorable and noncontroversial. The bill passed the Senate 55-0 and the House 112-0, indicating unanimous support in both chambers. No committee transcript was provided, but the voting history suggests broad bipartisan agreement on expanding preventive health coverage.
The main policy point embedded in the bill is whether insurers and public plans should be required to cover a specific preventive screening for peripheral artery disease, particularly for at-risk populations. Because the bill ties coverage to medical necessity and recognized clinical guidelines, there is little visible opposition in the available record. Any practical contention would likely center on implementation details, cost to plans, and how “at-risk individual” is defined under the referenced medical guidelines, but no recorded debate or dissent appears in the materials provided.
SB1418 expands mandated health insurance benefits in Illinois by adding peripheral artery disease screening to the list of required coverages and by conforming numerous public and private health-plan statutes to that new mandate. It affects state employee plans, county and municipal self-insured plans, school employee coverage, HMOs, limited health service organizations, voluntary health services plans, and the medical assistance program, while leaving enforcement primarily with the Department of Insurance and, for certain state employee provisions, the Department of Central Management Services.
The bill’s sentiment is overwhelmingly positive based on the voting record. It passed both chambers unanimously, with no recorded opposition in either the Senate or House. That level of support suggests the measure was viewed as a preventive-care expansion with broad appeal and little partisan or stakeholder resistance in the legislative process.
No formal contention is visible in the provided record, and there were no committee transcripts or recorded dissenting votes. The only likely areas of discussion would be the cost of adding a new mandated benefit, insurer compliance, and the scope of the medical guideline-based definition of at-risk individuals. The bill also touches multiple public-plan and insurance statutes, so implementation across different plan types could be a practical issue, but no specific opposition is documented here.